In this podcast, Darren Brenner, MD, from Northwestern Medicine, discusses the current management of irritable bowel syndrome (IBS), findings from the RELIEF phase 4 clinical trial of diarrhea-predominant IBS (IBS-D), why targeting underlying pathogenic mechanisms of IBS symptoms is the future of management, and more. For more content, visit consultant360.com/gastroenterology.